Arcadia Biosciences(RKDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RKDA Arcadia Biosciences

Pre-Mkt 05-12 04:52:49 EDT

1.06

-0.01

-0.93%

High1.14	Low1.05	Vol34.78K
Open1.13	D1 Closing1.07	Amplitude8.41%
Mkt Cap2.18M	Tradable Cap2.17M	Total Shares2.06M
T/O38.19K	T/O Rate1.70%	Tradable Shares2.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RKDA","market":"US","secType":"STK","nameCN":"Arcadia Biosciences","latestPrice":1.06,"timestamp":1778529600000,"preClose":1.07,"halted":0,"volume":34777,"delay":0,"changeRate":-0.009345794392523372,"floatShares":2045700,"shares":2056884,"eps":-1.709724,"marketStatus":"Pre-Mkt","change":-0.01,"latestTime":"05-12 04:52:49 EDT","open":1.125,"high":1.14,"low":1.05,"amount":38192.3147,"amplitude":0.084112,"askPrice":1.21,"askSize":100,"bidPrice":0.9694,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.709724,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778592600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1431662400000,"exchange":"NASDAQ","adjPreClose":1.06,"postHourTrading":{"tag":"盘后","latestPrice":1.06,"preClose":1.06,"latestTime":"16:04 EDT","volume":3,"amount":3.18,"timestamp":1778529885674,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3004861547837454,"impliedVol":3.7687,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/RKDA","defaultTab":"news","newsList":[{"id":"2624661176","title":"Arcadia Biosciences dismisses Deloitte, names Ramirez Jimenez International as new auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2624661176","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624661176?lang=en_us&edition=fundamental","pubTime":"2026-04-04 03:31","pubTimestamp":1775244710,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences Audit Committee dismissed Deloitte & Touche as independent auditor on March 30, 2026.Deloitte audit reports for fiscal 2025 and 2024 included a going-concern explanatory paragraph tied to accumulated deficit, recurring losses, cash burn.Company disclosed material weaknesses in internal control over financial reporting as of Dec. 31, 2025, citing reduced headcount that weakened segregation of duties and IT access controls.Ramirez Jimenez International CPAs was engaged as successor auditor effective March 30, 2026, starting with review of quarter ended March 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via EDGAR, the E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL8gDQGx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622896491","title":"Arcadia Biosciences FY2025 net loss attributable to common stockholders narrows 67% to $2.3 million; revenue drops 4% to $4.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622896491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622896491?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:09","pubTimestamp":1774555764,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences FY2025 net loss attributable to common stockholders narrows 67% to $2.3 million; revenue drops 4% to $4.9 million. Arcadia Biosciences filed a Form 8-K reporting Q4 and FY 2025 results, including Q4 total revenues of 901,000 USD, down 26%.FY total revenues were 4.86 million USD, down 4%, as higher Zola revenues were offset by no GLA oil sales.Q4 net loss attributable to common stockholders was 1.34 million USD, compared with a net loss of 4.06 million USD a year earlier.FY net loss attributable to common stockholders was 2.34 million USD, compared with a net loss of 7.04 million USD a year earlier.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL3JrVxm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622922896","title":"BRIEF-Arcadia Biosciences Q4 Net Income USD -1.336 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622922896","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622922896?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:05","pubTimestamp":1774555546,"startTime":"0","endTime":"0","summary":"BRIEF-Arcadia Biosciences Q4 Net Income USD -1.336 Million\n\n\nMar 26 (Reuters) - Arcadia Biosciences Q4 operating expenses USD 2.276 million.\n\nQ4 revenue USD 901 thousand","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nPLX9CA113:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622889165","title":"Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2622889165","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622889165?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:05","pubTimestamp":1774555500,"startTime":"0","endTime":"0","summary":"-- Zola revenues increase 17% year-over-year -- -- Arcadia and Roosevelt Resources terminate proposed business combination -- -- Exercise of preferred investment options yields $2.1 million gross proc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/26/3263397/35730/en/Arcadia-Biosciences-RKDA-Announces-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609113635","title":"Zwei Vorstandsmitglieder von Arcadia Biosciences Inc. treten zurück","url":"https://stock-news.laohu8.com/highlight/detail?id=2609113635","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609113635?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:04","pubTimestamp":1770411879,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences Inc. hat bekannt gegeben, dass Albert D. Bolles, Ph.D., und Deborah Carosella mit Wirkung zum 4. Februar 2026 aus dem Vorstand des Unternehmens ausgeschieden sind. Beide werden dem Unternehmen weiterhin beratend zur Verfügung stehen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL4MCZVW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606718590","title":"Arcadia Biosciences files to sell 1.67M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2606718590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606718590?lang=en_us&edition=fundamental","pubTime":"2026-01-28 19:10","pubTimestamp":1769598622,"startTime":"0","endTime":"0","summary":"06:09 EST Arcadia Biosciences (RKDA) files to sell 1.67M shares of common stock for holders Published first on TheFly – the ultimate source for rea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcadia-biosciences-files-to-sell-1-67m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcadia-biosciences-files-to-sell-1-67m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603618887","title":"BRIEF-Arcadia Biosciences Enters Inducement Offer Letter Agreements With Certain Investors  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603618887","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603618887?lang=en_us&edition=fundamental","pubTime":"2026-01-14 19:41","pubTimestamp":1768390900,"startTime":"0","endTime":"0","summary":"BRIEF-Arcadia Biosciences Enters Inducement Offer Letter Agreements With Certain Investors  - SEC FilingJan 14  - SEC Filing:ARCADIA BIOSCIENCES INC - ENTERS INDUCEMENT OFFER LETTER AGREEMENTS WITH CERTAIN INVESTORS  - SEC FILINGARCADIA BIOSCIENCES INC - INVESTORS TO PURCHASE 808,595 SHARES OF OF THE CO'S COMMON STOCK- SEC FILINGSource text: [ID:n0001193125-26-012028]Further company coverage: RKDA.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF0T7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602510833","title":"Arcadia Biosciences Raises $2.1 Million Through Exercise of Preferred Investment Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510833","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510833?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:01","pubTimestamp":1768222898,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences Inc. announced the immediate exercise of certain outstanding preferred investment options, allowing the purchase of up to 808,595 shares of common stock at a reduced exercise price of $2.575 per share, down from the original $9.00 per share. The company expects to receive approximately $2.1 million in gross proceeds from this transaction, before deducting placement agent fees and offering expenses. In connection with this exercise, Arcadia will also issue new unregistered preferred investment options to purchase up to 1,617,190 shares of common stock at an exercise price of $2.325 per share. These new options are immediately exercisable and will expire thirty months after the effective date of a forthcoming resale registration statement. Net proceeds will be used for working capital and general corporate purposes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8sGFDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4588","SG9999014039.USD","SG9999014021.USD","BK4585","RKDA","LU0314104364.USD","LU2210150020.SGD","BK4189","IE00BKPKM429.USD","BK4112","IE00B64PRP62.GBP","LU2210149790.SGD","LU2095319765.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","NDAQ","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594574299","title":"Arcadia Biosciences Receives Notice of Termination for Roosevelt Resources Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2594574299","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594574299?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:02","pubTimestamp":1766754131,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences has received a notice from Roosevelt Resources, LP, terminating the Securities Exchange Agreement between the two companies that was originally signed on December 4, 2024. The agreement had provided for a proposed business combination. Following the termination, Arcadia plans to resume evaluating strategic alternatives, citing its streamlined operations, reduced expenses, ownership of shares in Above Food Ingredients Inc., and ongoing growth of the Zola coconut water brand as assets that may support future transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire  on December 26, 2025, and is solely responsi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251226:nNDL92mxs4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014013.SGD","BK4212","BK4189","IE00BKPKM429.USD","BK4585","ABVE","LU2095319765.USD","BK4112","SG9999014039.USD","IE00B64PRP62.GBP","BK4588","LU0314104364.USD","LU2210150020.SGD","NDAQ","RKDA","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594995792","title":"Arcadia Biosciences (Rkda) Receives Termination Notice of the Proposed Business Combination With Roosevelt Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2594995792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594995792?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:02","pubTimestamp":1766754120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251226:nTUA557V83:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594299509","title":"Arcadia Biosciences Inc - to Evaluate Strategic Alternatives for Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2594299509","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594299509?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:02","pubTimestamp":1766754120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251226:nTUA557V83:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593443464","title":"Arcadia Biosciences Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2593443464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593443464?lang=en_us&edition=fundamental","pubTime":"2025-12-24 05:31","pubTimestamp":1766525467,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences Inc. held its annual meeting of stockholders on December 19, 2025. Shareholders elected three director nominees to the board. Approval was also given for the selection of Deloitte & Touche LLP as the independent registered public accountants for the year ending December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL1X4SbN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584976318","title":"Arcadia Biosciences Inc. Announces Date for Upcoming Annual Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2584976318","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584976318?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:31","pubTimestamp":1763587908,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences Inc. will hold its Annual Meeting of Stockholders on December 19, 2025. Shareholders will have the opportunity to vote on various matters presented for their consideration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcadia Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL512n2F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584921865","title":"Arcadia Biosciences Q3 Net Income USD 856 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2584921865","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584921865?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:07","pubTimestamp":1763572046,"startTime":"0","endTime":"0","summary":"Nov 07 (Reuters) - Arcadia Biosciences Q3 revenue USD 1.302 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 07-NOV-202521:05:46.137 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD2wz4GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581831536","title":"Arcadia Biosciences Q3 revenue falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2581831536","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581831536?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:15","pubTimestamp":1762550159,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences Q3 revenue fallsOverviewArcadia Q3 revenue declines 15% yr/yr, missing analyst expectationsNet income for Q3 beats analyst estimates, driven by unrealized gain on ABVE stockArcadia","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL1N3WJ16N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVE","RKDA","BK4212","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581390088","title":"Arcadia Biosciences Q3 EPS $0.63, Sales $1.302M Miss $1.900M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581390088","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581390088?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:07","pubTimestamp":1762549671,"startTime":"0","endTime":"0","summary":"Arcadia Biosciences Q3 EPS $0.63, Sales $1.302M Miss $1.900M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48734615/arcadia-biosciences-q3-eps-0-63-sales-1-302m-miss-1-900m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Arcadia Biosciences Q3 EPS $0.63, Sales $1.302M Miss $1.900M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581029839","title":"BRIEF-Arcadia Biosciences Q3 Net Income USD 856 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2581029839","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581029839?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:05","pubTimestamp":1762549546,"startTime":"0","endTime":"0","summary":"BRIEF-Arcadia Biosciences Q3 Net Income USD 856 Thousand\n\n\nNov 07 (Reuters) - Arcadia Biosciences Q3 revenue USD 1.302 million.\n\nQ3 operating expenses USD 2.454 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nPLX193A28:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581081839","title":"Arcadia Biosciences Q3 Revenue USD 1.302 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581081839","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581081839?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:05","pubTimestamp":1762549501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nPLX193A28:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RKDA","BK4189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581839045","title":"Press Release: Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2581839045","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581839045?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:05","pubTimestamp":1762549500,"startTime":"0","endTime":"0","summary":"-- Zola year-to-date revenues increase 26% year over year --. -- Arcadia gross profit margins exceed 30% for 11 straight quarter --. -- Arcadia cash balance declines by only $257K to $1.1M --. DALLAS, Nov. 07, 2025  -- Arcadia Biosciences, Inc. , a producer and marketer of innovative wellness products, today released its financial and business results for the third quarter of 2025.\"We are very pleased with our performance for the third quarter of 2025.\" said T.J. Schaefer, CEO of Arcadia. \"Zola coconut water revenues were flat year-over-year in the third quarter as we overlapped the initial sell-in to Zola's largest customer during the third quarter of 2024. However, on a year-to-date basis, Zola coconut water revenues have grown 26% and more than offset $700,000 in GLA sales in 2024 that did not occur in 2025. Additionally, our gross margins have now exceeded 30% for eleven consecutive quarters, SG&A expenses are at an all-time low and our cash management exceeded our expectations.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","R","ABVE","BK4189","BK4099","BK4585","BK4555","BK4588","BK4604","03160","RKDA","BK4232","BK4212","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578547492","title":"Arcadia Biosciences Announces 2025 Annual Meeting Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2578547492","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578547492?lang=en_us&edition=fundamental","pubTime":"2025-10-25 03:27","pubTimestamp":1761334059,"startTime":"0","endTime":"0","summary":"The latest update is out from Arcadia Biosciences ( ($RKDA) ). Arcadia Biosciences, Inc. has announced that its 2025 annual meeting of stockholders...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arcadia-biosciences-announces-2025-annual-meeting-date?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arcadia-biosciences-announces-2025-annual-meeting-date?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4189","RKDA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcadiabio.com","stockEarnings":[{"period":"1week","weight":-0.1167},{"period":"1month","weight":-0.197},{"period":"3month","weight":-0.4011},{"period":"6month","weight":-0.7039},{"period":"1year","weight":-0.7267},{"period":"ytd","weight":-0.4646}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.0881},{"period":"3month","weight":0.0682},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.31},{"period":"ytd","weight":0.0841}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.034513},{"month":2,"riseRate":0.363636,"avgChangeRate":0.0867},{"month":3,"riseRate":0.181818,"avgChangeRate":0.26799},{"month":4,"riseRate":0.181818,"avgChangeRate":-0.0932},{"month":5,"riseRate":0.545455,"avgChangeRate":0.041333},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.089658},{"month":7,"riseRate":0.181818,"avgChangeRate":-0.110678},{"month":8,"riseRate":0.545455,"avgChangeRate":0.235192},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.198577},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.040169},{"month":11,"riseRate":0.272727,"avgChangeRate":-0.084204},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.016763}],"exchange":"NASDAQ","name":"Arcadia Biosciences","nameEN":"Arcadia Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcadia Biosciences(RKDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Arcadia Biosciences(RKDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Arcadia Biosciences,RKDA,Arcadia Biosciences股票,Arcadia Biosciences股票老虎,Arcadia Biosciences股票老虎国际,Arcadia Biosciences行情,Arcadia Biosciences股票行情,Arcadia Biosciences股价,Arcadia Biosciences股市,Arcadia Biosciences股票价格,Arcadia Biosciences股票交易,Arcadia Biosciences股票购买,Arcadia Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcadia Biosciences(RKDA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Arcadia Biosciences(RKDA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}